At DZD, we are developing a sequencing-based rapid diagnostic that identifies, within hours, both the species and the antibiotic resistance profile of a bacterial pathogen. Currently approaches take 2-5 days to provide similar information, a time delay that is associated with an 8% increase in death per hour for severe infections.

We use high throughput sequencing technologies and proprietary machine learning algorithms to rapidly predict pathogen species and drug resistance profiles. Our approach allows for the simultaneous testing of every known bacterial species and resistance marker, along with the ability to identify novel resistance determinants as they emerge. Using our diagnostic, hospitals will be able to dramatically reduce hospital length of stay, the overuse of expensive and often ineffective antibiotics, and most importantly, excess mortality.